Thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
US9073907B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 12, 2010 |
| Grant date | Jul 7, 2015 |
| Priority date | — |
| Expiry date | Feb 29, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds of Formula (I), wherein M, P, A and (B)n are defined as in Formula (I); invention compounds are modulators of metabotropic glutamate receptors—subtype 4 (“mGluR4”) which are useful for the treatment or prevention of central nervous system disorders as well as other disorders modulated by mGluR4 receptors. The invention is also directed to pharmaceutical compositions and the use of such compounds in the manufacture of medicaments, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR4 is involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.